Ion Exchange (India) Limited

Q1 FY25 Financial Performance:

  • Consolidated operating income: ₹5,676 million, up 18% YoY.
  • EBITDA: ₹641 million, representing a 31% YoY increase; EBITDA margin: 11.29%.
  • Net profit: ₹448 million, a 35% YoY increase; PAT margin: 7.89%.

Segmental Performance:

1. Engineering Division:

  • Revenue: ₹3,235 million, a 13% YoY increase.
  • EBIT: ₹188 million, up 26% YoY.
  • Steady order inflows for medium-sized jobs; robust domestic enquiry bank.
  • Total order book: ₹3,394 crores.
  • Execution of international contracts contributed to improved turnover.
  • Expecting increased pace of execution for larger EPC jobs in upcoming quarters.

2. Chemical Segment:

  • Revenue: ₹1,994 million, a 36% YoY increase.
  • EBIT: ₹498 million, also up 36% YoY; maintained steady margins.

3. Consumer Division:

  • Revenue: ₹660 million, a 9% YoY increase.
  • Reported a loss of ₹34 million, compared to a loss of ₹15 million YoY.
  • New product launches gaining market acceptance.

Order Book and Execution Insights:

  • Engineering division’s UP contract expected to be substantially executed by the end of FY25, dependent on fund releases and government approvals.
  • Current residual value of UP project: ₹813 crores; Q1 execution: ₹26 crores.
  • Anticipated significant improvement in execution from Q2 onwards, post-election-related cash flow impacts.

Management Changes:

  • Transitioning to Non-Executive Non-Independent Directors for certain management members to facilitate professional management and support growth.
  • CEO to assume role of Managing Director as part of planned management transition.

Strategic Focus and Market Positioning:

  • Positive outlook for the chemical segment; aiming for 15% growth, contingent on stable input prices and foreign exchange dynamics.
  • Ongoing capacity expansion in resins and chemicals targeted at international markets.
  • Enhanced focus on R&D and innovation to drive profitability and competitive edge.

Challenges and Headwinds:

  • Legacy project continues to impact margins; expected to taper out after Q2 FY25.
  • Execution delays attributed to election-related funding uncertainties.
  • Management remains cautiously optimistic about future order inflows and revenue growth.

Future Growth Prospects:

  • Anticipating substantial revenue growth from international markets, particularly in North America and Europe.
  • Continued investment in technology and capacity expansion to enhance profitability.
  • Maintaining a robust enquiry pipeline with ongoing evaluations for large engineering projects.

CAPEX and Expansion Plans:

  • Resin project nearing commercial operations expected in FY26; 3-4 years to reach optimum capacity utilization.
  • Expansion initiatives in Orissa for backward integration and capacity augmentation.
4 Likes

Company has been awarded Contracts from Adani Power Limited for Comprehensive & Complete
Total Water & Environment Management Solution valued at approx. INR. 161.19 Crores for
Process & Utility required of 2 x 800 MW units for Raipur & Raigarh Ultra Super Power Projects.
The projects are to be completed within 18 months from Project Award dates.

3 Likes

Takeaways from Q4 2025 Earning call

  • Engineering division faces significant execution and profitability headwinds, especially from UP order.
  • Consumer segment remains a loss-making division.
  • No clear outlook given for FY26 – management will reassess post H1.
  • Interest outflow expected to increase in FY26 as ~₹320 Cr debt (80% of ₹400 Cr capex) starts hitting P&L due to Roha’s commissioning and end of capitalization phase.
  • Only encouraging factor currently is Roha plant – expected to improve utilization, chemical segment revenues, and margins.
  • Expecting Further Valuation de-rating if Roha plant scale-up or execution recovery doesn’t materialize in H2 FY26.
1 Like

Yes. But once they are out of the UP & Sri Lankan project, the Engg division may improve. However the dark horse is the Chemicals division and the Roha Plant. When everyone is focusing on EPC & order book , this company has water treatment chemicals which is Key factor. But imho this will test the investor patience till the clarity emerges from Engg.

Disc: Invested